Aberrated supraventricular tachycardia associated with neonatal fever and COVID-19 infection

Kali A. Hopkins*, Gregory Webster

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

A 9-day-old girl presented during the 2020 SARS-CoV-2 pandemic in wide-complex tachycardia with acute, symptomatic COVID-19 infection. Because the potential cardiac complications of COVID-19 were unknown at the time of her presentation, we chose to avoid the potential risks of haemodynamic collapse associated with afterload reduction from adenosine. Instead, a transoesophageal pacing catheter was placed. Supraventricular tachycardia (SVT) with an aberrated QRS morphology was diagnosed and the catheter was used to pace-terminate tachycardia. This presentation illustrates that the haemodynamic consequences of a concurrent infection with largely unknown neonatal sequelae present a potentially high-risk situation for pharmacologic conversion. Oesophageal cannulation can be used to diagnose and terminate infantile SVT.

Original languageEnglish (US)
Article numbere241846
JournalBMJ case reports
Volume14
Issue number4
DOIs
StatePublished - Apr 30 2021
Externally publishedYes

Keywords

  • COVID-19
  • arrhythmias
  • pacing and electrophysiology
  • paediatrics

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Aberrated supraventricular tachycardia associated with neonatal fever and COVID-19 infection'. Together they form a unique fingerprint.

Cite this